References
- Ilboudo M, Zohoncon TM, Traore IMA, Traore EMA, Kande A, Obiri-Yeboah D, Djigma FW, Gyebre YMC, Simpore J. Implication of low risk human papillomaviruses, HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso. Am J Otolaryngol. 2019;40:368–71. doi:10.1016/j.amjoto.2019.02.003.
- Shehata BM, Otto KJ, Sobol SE, Stockwell CA, Foulks C, Lancaster W, Gregoire L, Hill CE. E6 and E7 Oncogene expression by human papilloma virus (HPV) and the aggressive behavior of recurrent laryngeal papillomatosis (RLP). Pediatr Dev Pathol.. 2008;11:118–21. doi:10.2350/06-09-0160.1.
- Nowińska K, Ceisielska U, Podhorska-Okołów M, Dzięgiel P. The role of human papillomavirus in oncogenic transformation and its contribution to the etiology of precancerous lesions and cancer of the larynx: a review. Adv Clin Exp Med.. 2017;26:539–47. doi:10.17219/acem/67461.
- Wilmot VV, Nixon IJ, Nixon IF. Small cell neuroendocrine carcinoma of tracheostomy site in a patient with a history of juvenile laryngeal papillomatosis. BMJ Case Rep. 2016; doi:10.1136/bcr-2016-216370.
- El-Achkar VNR, Duarte A, Saggioro FP, Filho FVDM, León JE, Ribeiro-Silva A, Kaminagakura E. Squamous cell carcinoma originating from adult laryngeal papillomatosis: case report and review of the literature. Case Rep Otolaryngol. 2018;2018:1–5. doi:10.1155/2018/4362162.
- Bzhalava D, Guan P, Franceschi S, Dillner J, Clifford G. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology. 2013;445:224–31. doi:10.1016/j.virol.2013.07.015.
- Rosenberg T, Philipsen BB, Mehlum CS, Dyrvig A-K, Wehberg S, Chirilǎ M, Godballe C. Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis. J Infect Dis. 2019;219:1016–1025. doi:10.1093/infdis/jiy616.
- Yeo-Teh N, Ito Y, Jha S. High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis. Int J Mol Sci. 2018;19:1706. doi:10.3390/ijms19061706.
- Hernandez BY, Rahman M, Lynch CF, Cozen W, Unger ER, Steinau M, Thompson T, Saber MS, Altekruse SF, Goodman MT, et al. p16(INK4A) expression in invasive laryngeal cancer. Papillomavirus Res. 2016;2:52–55. doi:10.1016/j.pvr.2016.03.001.
- Rabah R, Lancaster W, Thomas R, Gregoire L. Human Papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol. 2001;4:68–72. doi:10.1007/s100240010105.